Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial (vol 100, pg 1181, 2021)

Filiaciones

Heuser, Michael:

1 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Smith, B. Douglas:

2 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.

Fiedler, Walter:

3 Department of Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Sekeres, Mikkael A.:

4 Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.

Montesinos, Pau:

5 Hospital Universitari I Politècnic La Fe, Valencia, Spain.

6 CIBERONC, Instituto Carlos III, Madrid, Spain.

Leber, Brian:

7Juravinski Hospital At Hamilton Health Sciences, Hamilton, ON, Canada.

Merchant, Akil:

8 Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Papayannidis, Cristina:

9 IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Perez-Simon, Jose A.:

10 Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IbiS)/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.

Hoang, Caroline J.:

11 Pfizer Inc, New York, NY, USA.

O'Brien, Thomas:

11 Pfizer Inc, New York, NY, USA.

Ma, Weidong Wendy:

11 Pfizer Inc, New York, NY, USA.

Zeremski, Mirjana:

11 Pfizer Inc, New York, NY, USA.

O'Connell, Ashleigh:

11 Pfizer Inc, New York, NY, USA.

Chan, Geoffrey:

11 Pfizer Inc, New York, NY, USA.

Cortes, Jorge E.:

12 University of Texas MD Anderson Cancer Center, Houston, TX, USA.

13 Georgia Cancer Center, Augusta, GA, USA.